RHD*DOL1 and RHD*DOL2 encode a partial D antigen and are in cis with the rare RHCE*ceBI allele in people of African descent |
| |
Authors: | Michèle Roussel Sylvie Poupel Joëlle Nataf Geneviève Juszczak Geneviève Woimant Agnès Mailloux Cécile Menanteau Bach‐Nga Pham Philippe Rouger Pierre‐Yves Le Pennec Thierry Peyrard |
| |
Affiliation: | 1. From the Centre National de Référence pour les Groupes Sanguins (CNRGS);2. the Institut National de la Transfusion Sanguine (INTS);3. the Etablissement Fran?ais du Sang (EFS) Ile de France, Site Saint‐Vincent de Paul;4. and the Assistance Publique des H?pitaux de Paris, Centre National de Référence en Hémobiologie Périnatale (CNRHP), H?pital Saint‐Antoine, Paris, France. |
| |
Abstract: | BACKGROUND: Several studies showed in people of African descent the existence of a genetic linkage between RHD alleles encoding a variant D antigen and a given altered RHCE*ce allele. RHCE*ceBI is a rare allele encountered in people of African descent, that encodes a Hr– hrS– Rhce protein. Our study shows that RHCE*ceBI appears to be genetically linked to two very similar variant RHD alleles, RHD*DOL1 and RHD*DOL2, and demonstrates for the first time that DOL‐2 is a partial D antigen. STUDY DESIGN AND METHODS: After finding out an individual with both RHCE*ceBI and RHD*DOL presumed to be in cis, we hypothesized a genetic linkage between those two genes. All individuals (n = 7) known to carry RHCE*ceBI in our laboratory, including the index case, were fully investigated at the serologic and molecular level. RESULTS: One individual with alloanti‐D, being homozygous for RHCE*ceBI and RHD*DOL2, allowed us to confirm the genetic linkage between those two genes, as well as the partial D status of DOL‐2. In the six RHCE*ceBI remaining individuals, three were found with RHD*DOL2 and 3 with RHD*DOL1, likely in cis. Three of them made an alloanti‐D; one was DOL‐1 and two were DOL‐2. CONCLUSION: The rare RHCE*ceBI allele appears to be in cis either with RHD*DOL1 or with RHD*DOL2 in people of African descent. DOL‐1 and DOL‐2 must be considered as partial D antigens. We recommend a systematic search for RHD*DOL1 and RHD*DOL2 in people found to carry RHCE*ceBI and vice versa, especially in patients with sickle cell disease. |
| |
Keywords: | |
|
|